Medical Device Clinical Trials CEO Meeting

Uncovering the Best Practices in Completing Studies On-Time and On-Budget, Securing Regulatory Approval, and Opportunities in Working with Venture Capital Teams to Secure Funding.

March 9-11th, 2008
Palo Alto, CA

The Medical Device Clinical Trials California conference will be dedicated to, and focused on, providing strategic information to Medical Device Executives related to the completion of clinical research studies on-time and within budget parameters for start-up to medium sized corporations. Through focusing specifically upon the topics and challenges directly impacting these organizations, executives will have the opportunity to walk away with tangible solutions to the obstacles preventing them from completing their trials on schedule.

It is a known fact to both device executives as well as venture capital firms that clinical research is the most expensive stage of a medical device companies’ growth and development. During this stage, organizations are often burning through enormous amounts of funding, and in the end, find themselves short of the capital required to finish their studies. These clinical studies are often delayed due to shortfalls in subject recruitment, management of the sites, as well as not meeting difficult protocols from the FDA. This conference program will address these, and other important topics.

Sessions and Speakers Include:

Best Practices in Clinical Efficiency: Lower Operational Costs, Faster Time to Approval
Moderator:
Frank Fischer
Founder & CEO
NeuroPace

Reducing Burn Rates Throughout Clinical Research
Moderator:
Augustine Lien, PhD
Founder & CEO
Cardiva Medica

Recognizing the Impact of Clinical Research on Reimbursement, Coverage & Commercialization
Moderator:
Charles Carignan
Chief Medical Officer
Novasys Medical

And More...

For full registration details
Contact:

Paul Hernandez
Marketing Manager
PHernandez@Q1productions.com
312-602-9684